Literature DB >> 11582779

Purification of engineered human pancreatic ribonuclease.

M Ribó1, A Benito, A Canals, M V Nogués, C M Cuchillo, M Vilanova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11582779     DOI： 10.1016/s0076-6879(01)41154-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  8 in total

1.  The nuclear transport capacity of a human-pancreatic ribonuclease variant is critical for its cytotoxicity.

Authors:  Pere Tubert; Montserrat Rodríguez; Marc Ribó; Antoni Benito; Maria Vilanova
Journal:  Invest New Drugs       Date:  2010-03-30       Impact factor: 3.850

2.  Interactions crucial for three-dimensional domain swapping in the HP-RNase variant PM8.

Authors:  Pere Tubert; Douglas V Laurents; Marc Ribó; Marta Bruix; Maria Vilanova; Antoni Benito
Journal:  Biophys J       Date:  2011-07-20       Impact factor: 4.033

3.  Destabilizing mutations alter the hydrogen exchange mechanism in ribonuclease A.

Authors:  Marta Bruix; Marc Ribó; Antoni Benito; Douglas V Laurents; Manuel Rico; Maria Vilanova
Journal:  Biophys J       Date:  2008-01-11       Impact factor: 4.033

4.  A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation.

Authors:  Jessica Castro; Marc Ribó; Susanna Navarro; Maria Victòria Nogués; Maria Vilanova; Antoni Benito
Journal:  BMC Cancer       Date:  2011-01-11       Impact factor: 4.430

5.  Hybridase activity of human ribonuclease-1 revealed by a real-time fluorometric assay.

Authors:  Nicoletta Potenza; Vincenzo Salvatore; Annalucia Migliozzi; Valentina Martone; Valentina Nobile; Aniello Russo
Journal:  Nucleic Acids Res       Date:  2006-05-31       Impact factor: 16.971

6.  A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.

Authors:  Anna Vert; Jessica Castro; Marc Ribó; Antoni Benito; Maria Vilanova
Journal:  Oncotarget       Date:  2016-04-05

Review 7.  Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells.

Authors:  Sandra Jordaan; Olusiji A Akinrinmade; Thomas Nachreiner; Christian Cremer; Krupa Naran; Shivan Chetty; Stefan Barth
Journal:  Biomedicines       Date:  2018-03-05

8.  The Selectivity for Tumor Cells of Nuclear-Directed Cytotoxic RNases Is Mediated by the Nuclear/Cytoplasmic Distribution of p27KIP1.

Authors:  Glòria García-Galindo; Jessica Castro; Jesús Matés; Marlon Bravo; Marc Ribó; Maria Vilanova; Antoni Benito
Journal:  Molecules       Date:  2021-03-02       Impact factor: 4.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.